Core-shell hybrid liposomal vesicles loaded with panax notoginsenoside: Preparation, characterization and protective effects on global cerebral ischemia/reperfusion injury and acute myocardial ischemia in rats

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 4299-4310

  Zhang, Jing ^a   Han, Xizhen ^a   Li, Xiang ^a   Luo, Yun ^a   Zhao, Haiping ^a   Yang, Ming ^a   Ni, Bin ^a   Liao, Zhenggen ^a  

^a JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

In vivo animal models; Liposomes; Nanoparticles; Panax notoginsenoside; Physicochemical properties

Indexed keywords

CORE SHELL HYBRIDE LIPOSOMAL VESICLE; DRUG CARRIER; GINSENOSIDE; LACTATE DEHYDROGENASE; LIPOSOME; MALONALDEHYDE; NANOPARTICLE; PANAX NOTOGINSENOSIDE; PLANT MEDICINAL PRODUCT; PROTECTIVE AGENT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; IN VIVO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIGHT SCATTERING; MALE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; REPERFUSION INJURY; ZETA POTENTIAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BRAIN CHEMISTRY; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOTONIC AGENTS; DRUG STABILITY; DRUGS, CHINESE HERBAL; GINSENOSIDES; L-LACTATE DEHYDROGENASE; LIPOSOMES; MALE; MYOCARDIAL ISCHEMIA; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; WATER;

ANIMALIA; PANAX; RATTUS;

EID: 84870373570     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S32385     Document Type: Article

References (42)

1. Lei XL, Chiou GC. Cardiovascular pharmacology of Panax notoginseng (Burk) FH. Chen and Salvia miltiorrhiza. Am J Chin Med. 1986; 14(3-4):145-152.
2. Cicero AF, Vitale G, Savino G, Arletti R. Panax notoginseng (Burk) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet. Phytother Res. 2003;17(2):174-178.
3. Chen ZH, Li J, Liu J, etal. Saponins isolated from the root of Panax notoginseng showed significant anti-diabetic effects in KK-Ay mice. Am J Chin Med. 2008;36(5):939-951.
4. Peng XD, Dai LL, Huang CQ, He CM, Yang B, Chen LJ. Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis. Biochem Biophys Res Commun. 2009; 388(1):31-34.
5. Luo FC, Wang SD, Qi L, Song JY, Lv T, Bai J. Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo. J Ethnopharmacol. 2011;133(2): 448-453.
6. Sun K, Wang CS, Guo J, etal. Protective effects of ginsenoside Rb1, ginsenoside Rg1, and notoginsenoside R1 on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery. Life Sci. 2007; 81(6):509-518.
7. Chen XC, Zhu YG, Zhu LA, etal. Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12cells by suppressing oxidative stress. Eur J Pharmacol. 2003;473(1):1-7.
8. Cicero AFG, Bandieri E, Arletti R. Orally administered Panax notoginseng influence on rat spontaneous behavior. J Ethnopharmacol. 2000;73(3):387-391.
9. Sun S, Wang CZ, Tong R, etal. Effects of steaming the root of Panax notoginseng on chemical composition and anticancer activities. Food Chem. 2010;118(2):307-314.
10. Zhao GR, Xiang ZJ, Ye TX, Yuan YJ, Guo ZX. Antioxidant activities of Salvia miltiorrhiza and Panax notoginseng. Food Chem. 2006;99(4): 767-774.
11. Kwok HH, Ng WY, Yang MS, Mak NK, Wong RN, Yue PY. The ginsenoside protopanaxatriol protects endothelial cells from hydrogen peroxide-induced cell injury and cell death by modulating intracellular redox status. Free Radic Biol Med. 2010;48(3):437-445.
12. Feng L, Jiang XH. Study on the pharmacokinetic behavior of Panax notoginseng saponins in rat. West China J Pharm Sci. 2010;25(1): 46-49.
13. Takino Y, Odani T, Tanizawa H, Hayashi T. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. I. Quantitative analysis of Ginsenoside Rg1in rats. Chem Pharm Bull. 1982;30(6):2196-2201.
14. Odani T, Tanizawa H, Takino Y. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. The absorption, distribution and excretion of ginsenoside Rg1in the rat. Chem Pharm Bull. 1983;31(1):292-298.
15. Karikura M, Miyase T, Tanizawa H, Taniyama T, Takino Y. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and-Rb2in the digestive tract of rats. Chem Pharm Bull. 1991;39(9): 2357-2361.
16. Lee J, Lee E, Kim D, Lee J, Yoo J, Koh B. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J Ethnopharmacol. 2009;122(1):143-148.
17. Xiong J, Guo JX, Huang LS, Meng BY, Ping QN. Self-micelle formation and the incorporation of lipid in the formulation affect the intestinal absorption of Panax notoginseng. Int J Pharm. 2008;360(1-2): 191-196.
18. Zou L, Leng J, Liu Y, Zhao G. Progress of new preparations of Panax notoginseng saponins. J Sichuan Trad Chin Med. 2010;28(3):23-25.
19. Lee CM, Lee HC, Lee KY. O-Palmitoylcurdlan sulfate (OPCurS)-coated liposomes for oral drug delivery. J Biosci Bioeng. 2005;100(3): 255-259.
20. Wang SL, Zhang J, Jiang TY, etal. Protective effect of coenzyme Q10 against oxidative damage in human lens epithelial cells by novel ocular drug carriers. Int J Pharm. 2011;403(1-2):219-229.
21. Haidar ZS, Hamdy RC, Tabrizian M. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. Biomaterials. 2008;29(9): 1207-1215.
22. Takeuchi H, Yamamoto H, Toyoda T, Toyobuku H, Hino T, Kawashima Y. Physical stability of size controlled small unilamellar liposomes coated with a modified polyvinyl alcohol. Int J Pharm. 1998;164(1-2): 103-111.
23. Dai JD, Nagai T, Wang XQ, Zhang T, Meng M, Zhang Q. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Int J Pharm. 2004;280(1-2):229-240.
24. Panyam J, Labhasetwar V. Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol Pharm. 2004;1(1):77-84.
25. Avgoustakis K, Beletsi A, Panagi Z, etal. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int J Pharm. 2003; 259(1-2):115-127.
26. Ueno Y, Futagawa H, Takagi Y, Ueno A, Mizushima Y. Drug-incorporating calcium carbonate nanoparticles for a new delivery system. J Control Release. 2005;103(1):93-98.
27. Cascone MG, Lazzeri L, Carmignani C, Zhu Z. Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate. J Mater Sci Mater Med. 2002;13(5):523-526.
28. Tewes F, Munnier E, Antoon B, etal. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm. 2007;66(3): 488-492.
29. Govender T, Riley T, Ehtezazi T, etal. Defining the drug incorporation properties of PLA-PEG nanoparticles. Int J Pharm. 2000;199(1): 95-110.
30. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release. 2002;79(1-3):123-135.
31. Zhang J, Guan PP, Wang TY, Chang D, Jiang TY, Wang SL. Freeze-dried liposomes as potential carriers for ocular administration of cytochrome c against selenite cataract formation. J Pharm Pharmacol. 2009;61(9):1171-1178.
32. Zhang J, Wang SL. Topical use of Coenzyme Q10-loaded liposomes coated with trimethyl chitosan: Tolerance, precorneal retention and anti-cataract effect. Int J Pharm. 2009;372(1-2):66-75.
33. Xiang Q, Xiao J, Zhang HB, etal. Preparation and characterisation of bFGF-encapsulated liposomes and evaluation of wound-healing activities in the rat. Burns. 2011;37(5):886-895.
34. Mukherjee PK, Ahamed KFH, Kumar V, Mukherjee K, Houghton PJ. Protective effect of biflavones from Araucaria bidwillii Hook in rat cerebral ischemia/reperfusion induced oxidative stress. Behav Brain Res. 2007;178(2):221-228.
35. Hong JT, Ryu SR, Kim HJ, etal. Protective effect of green tea extract on ischemia/reperfusion-induced brain injury in Mongolian gerbils. Brain Res. 2001;888(1):11-18.
36. Chen Q. Experimental Methodology of TCM Pharmacology. 2nd ed. Beijing, China: People's Medical Publishing House; 2006.
37. Han M, Han LM, Wang QS, etal. Mechanism of oral absorption of panaxnotoginseng saponins. Acta Pharmaceutica Sin. 2006;41(6):498-505.
38. He CY, Li XH, He XF. Effect of different combinations of sanchinoside monomers on monocyte-endotheliocyte adhesion. J Traditional Chin Med. 2007;48(4):354-361.
39. Siesjo{double acute} BK. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J Neurosurg. 1992;77(3): 337-354.
40. Rodrigo R, Guichard C, Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam Clin Pharmacol. 2007; 21(2):111-127.
41. Dong TT, Cui XM, Song ZH, etal. Chemical assessment of roots of Panax notoginseng in China: regional and seasonal variations in its active constituents. J Agric Food Chem. 2003;51(16):4617-4623.
42. Wu L, Zhang W, Tang YH, etal. Effect of total saponins of "panax notoginseng root" on aortic intimal hyperplasia and the expressions of cell cycle protein and extracellular matrix in rats. Phytomedicine. 2010;17(3-4):233-240.